- Home
- CRVS vs OM Comparison
CRVS vs OM Comparison
Compare CRVS & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- OM
- Stock Information
- Founded
- CRVS 2014
- OM 2003
- Country
- CRVS United States
- OM United States
- Employees
- CRVS N/A
- OM 354
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRVS Health Care
- OM Health Care
- Exchange
- CRVS Nasdaq
- OM Nasdaq
- Market Cap
- CRVS 305.4M
- OM 247.1M
- IPO Year
- CRVS 2016
- OM 2020
- Fundamental
- Price
- CRVS $5.75
- OM $13.91
- Analyst Decision
- CRVS Strong Buy
- OM Hold
- Analyst Count
- CRVS 4
- OM 1
- Target Price
- CRVS $15.00
- OM $22.00
- AVG Volume (30 Days)
- CRVS 518.7K
- OM 288.8K
- Earning Date
- CRVS 08-07-2025
- OM 08-06-2025
- Dividend Yield
- CRVS N/A
- OM N/A
- EPS Growth
- CRVS N/A
- OM N/A
- EPS
- CRVS N/A
- OM N/A
- Revenue
- CRVS N/A
- OM $119,304,000.00
- Revenue This Year
- CRVS N/A
- OM $12.37
- Revenue Next Year
- CRVS N/A
- OM $10.52
- P/E Ratio
- CRVS N/A
- OM N/A
- Revenue Growth
- CRVS N/A
- OM 2.47
- 52 Week Low
- CRVS $2.54
- OM $5.85
- 52 Week High
- CRVS $10.00
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- OM 43.41
- Support Level
- CRVS $5.28
- OM $13.60
- Resistance Level
- CRVS $5.64
- OM $14.35
- Average True Range (ATR)
- CRVS 0.30
- OM 0.60
- MACD
- CRVS 0.03
- OM 0.26
- Stochastic Oscillator
- CRVS 77.70
- OM 80.09
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.